Driehaus Micro Cap Growth Fund DMCRX

Medalist Rating as of | See Driehaus Investment Hub
  • NAV / 1-Day Return 18.47  /  +0.33 %
  • Total Assets 522.2M
  • Adj. Expense Ratio
    1.340%
  • Expense Ratio 1.300%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 10,000
  • Status Limited
  • TTM Yield 0.22%
  • Turnover 142%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:22 AM GMT+0

Morningstar’s Analysis DMCRX

Will DMCRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Driehaus Micro Cap Growth holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DMCRX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 17.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Northern Institutional US Govt Sel

3.54 19M
Cash and Equivalents

Definium Therapeutics Inc Ordinary Shares

2.53 13M
Healthcare

Spyre Therapeutics Inc

2.48 13M
Healthcare

Praxis Precision Medicines Inc Ordinary Shares

2.13 11M
Healthcare

nLight Inc

1.75 9M
Technology

Kiniksa Pharmaceuticals International PLC Class A

1.58 8M
Healthcare

Bandwidth Inc Class A

1.55 8M
Technology

Lindblad Expeditions Holdings Inc

1.49 8M
Consumer Cyclical

Xometry Inc Ordinary Shares - Class A

1.48 8M
Industrials

MBX Biosciences Inc

1.47 8M
Healthcare

Sponsor Center